Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and NIH Clinical Center operations was added, and the page now shows a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:45:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The updates are minor editorial changes to UI text and versioning, including adding a 'Show glossary' option, correcting capitalization in labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act Data', and updating the revision from v3.3.4 to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-28T06:37:04.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed. No changes to study content or page functionality.
    Difference
    0.0%
    Check dated 2026-01-14T02:55:40.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing participating states for the Cypress-1 trial (rev. v3.3.3).
    Difference
    2%
    Check dated 2025-12-23T17:06:47.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    These changes are minor editorial updates to the Publications section, noting that PubMed publications are automatically populated, and the page revision has moved from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T18:54:34.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The government funding status notice was removed from the page. This change does not modify the study details, eligibility criteria, outcomes, or other substantive content.
    Difference
    0.2%
    Check dated 2025-11-17T18:02:25.000Z thumbnail image

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.